Early detection of Alzheimer's Disease in the military population Top
Alzheimer’s disease (AD) is a neurodegenerative disease that is currently affecting more than five million Americans. The aging military veterans are one of the populations most affected with Alzheimer’s disease. Evidence suggest that this aging military population has potentially been subjected to additional risk factors compared to the general population. Consequently, it is believed that this population represents an elevated risk for AD and other dementias. Therefore, the goal of our study was to use existing statistical classification methods to be able to detect AD at an early stage and determine important biomarkers for the military population.
Alzheimer’s disease (AD) is the most common form of dementia. It is an irreversible and neurodegenerative disease. There are more than five million Americans living with Alzheimer’s disease and by 2050 it is estimated that this number will rise to 16 million (Alzheimer's disease facts and figures.2017). According to the Alzheimer’s Association, by the end of 2017, AD and other dementias will cost Americans 259 million dollars; it is estimated that these costs could rise as high as 1.1 trillion dollars by 2050. This makes it the most expensive disease in America and it cost more than heart disease and cancer (Alzheimer's disease facts and figures.2017).
read more...
